Xvivo Perfusion
274.40 SEK
-0.72 %
Less than 1K followers
XVIVO
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Xvivo Perfusion
P/E
Median 2019-2025
EV/S
Median 2019-2024
EV/EBIT
Median 2019-2024
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 170.00 | 314.00 | 278.50 | 183.00 | 329.50 | 489.00 | 186.60 |
| Shares | 26.5 | 27.0 | 28.7 | 29.8 | 31.5 | 31.5 | 31.5 |
| Market cap | 4,502.3 | 8,482.1 | 7,998.2 | 5,459.2 | 10,379.1 | 15,403.2 | 5,877.8 |
| Enterprise value | 4,347.9 | 8,197.6 | 7,605.3 | 5,222.7 | 9,864.4 | 15,021.8 | - |
| EV/S | 19.7 | 45.6 | 29.4 | 12.6 | 16.5 | 18.3 | - |
| EV/EBITDA | 151.0 | neg. | 552.7 | 107.5 | 122.5 | 85.3 | - |
| EV/EBIT | 1,103.5 | neg. | neg. | 814.8 | 2,354.3 | 170.0 | - |
| P/E | 912.0 | neg. | 981.3 | 295.2 | 107.3 | 89.4 | 233.2 |
| P/B | 7.80 | 8.41 | 6.22 | 3.82 | 5.34 | 7.14 | 2.78 |
| P/S | 20.4 | 47.2 | 31.0 | 13.1 | 17.4 | 18.7 | 7.2 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 91.0 % | 87.7 % | 83.3 % | 82.5 % | 89.2 % | 89.8 % | 89.0 % |
| Gearing ratio | 1.0 % | 6.9 % | 0.4 % | 0.7 % | 1.6 % | 1.6 % | 5.9 % |